Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126225531 | 12622553 | 1 | I | 20160315 | 20160804 | 20160804 | PER | GXBR2016US000974 | SANDOZ | 0.00 | M | Y | 81.50000 | KG | 20160804 | PH | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126225531 | 12622553 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 2.5 MG, BID | N | 65461 | 2.5 | MG | CAPSULE | BID | |||||
| 126225531 | 12622553 | 2 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | 3 MG, BID | N | 65461 | 3 | MG | CAPSULE | BID | |||||
| 126225531 | 12622553 | 3 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | UNK DF, UNK | 0 | |||||||||||
| 126225531 | 12622553 | 4 | C | MAGNESIUM CHLORIDE. | MAGNESIUM CHLORIDE | 1 | UNK DF, UNK | 0 | |||||||||||
| 126225531 | 12622553 | 5 | C | MULTI-VIT | VITAMINS | 1 | UNK DF, UNK | 0 | |||||||||||
| 126225531 | 12622553 | 6 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | UNK DF, UNK | 0 | |||||||||||
| 126225531 | 12622553 | 7 | C | ZOLPIDEM | ZOLPIDEMOLPIDEM TARTRATE | 1 | UNK DF, UNK | 0 | |||||||||||
| 126225531 | 12622553 | 8 | C | DOCUSATE | DOCUSATE | 1 | UNK DF, UNK | 0 | |||||||||||
| 126225531 | 12622553 | 9 | C | ACETAMINOPHEN W/HYDROCODONE | ACETAMINOPHENHYDROCODONE | 1 | UNK DF, UNK | 0 | |||||||||||
| 126225531 | 12622553 | 10 | C | FLUTICASONE | FLUTICASONEFLUTICASONE PROPIONATE | 1 | UNK DF, UNK | 0 | |||||||||||
| 126225531 | 12622553 | 11 | C | INDOMETHACIN. | INDOMETHACIN | 1 | UNK DF, UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126225531 | 12622553 | 1 | Immunosuppression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126225531 | 12622553 | Diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126225531 | 12622553 | 1 | 20140715 | 20140903 | 0 | |
| 126225531 | 12622553 | 2 | 20140404 | 20140714 | 0 |